Clinical
Friday, September 14, 2018

How is QIAGEN enabling genomics-guided precision medicine?

 

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to enhance patient care, QIAGEN has made it mission critical to enable genomics-guided precision medicine.

 

Check out this recent article by American Health Leader (AHL) on how QIAGEN is helping clinical diagnostic and pathology labs adopt genomics-guided precision medicine workflows.

Sean P. Scott, Chief Business Officer and Vice President of Clinical Market Development at QIAGEN, explains QIAGEN’s holistic approach to developing and expanding NGS-based test services. “No matter the size of the lab, we’re focused on helping them understand how to develop a more insightful and actionable report for the ordering physician . . .”

 

Read the full article here!


Want to establish or expand your clinical NGS program?
Expand with QCI Interpret.

QCI Interpret makes precision medicine possible by offering one, cloud-based platform to handle a range of genomic testing, from somatic to germline, from small panels to exome and whole genome.

 

Get in touch with one of our QCI Interpret experts today!

CONTACT US

 


Do you need a clinical reporting solution that is highly accurate, reproducible and standardized?

If you answered yes, we invite you to watch a free recording of our webinar that addresses one of the key bottlenecks of today’s clinical testing laboratory: producing standardized interpretation that is consistent among personnel, reproducible within the testing community, and in accordance with professional guidelines. We show how our clinical NGS reporting and interpretation software, QCI Interpret, not only makes precision medicine possible, but simplifies workflows and increases productivity.

 

 

Interested in learning more about QCI Interpret?

CONTACT US

 


 


© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers